Skip to main content
Premium Trial:

Request an Annual Quote

Watson Extends its Reach

Premium

Clinicians and researchers at Memorial Sloan-Kettering Cancer Center have a new weapon in their cancer-fighting arsenal — IBM's Watson supercomputer. IBM and Sloan-Kettering are collaborating on the development of a new service featuring Watson, reports Bloomberg's Beth Jinks. The computer will assist doctors in making diagnoses and treatment decisions by mining current information and alerting doctors to new developments and research, Jinks says. A statement from Sloan-Kettering and IBM calls the Watson service a "decision support tool," and says it gives doctors access to much more information than they could possibly gather by themselves. "Watson is being taught oncology and being programmed with the types of questions it will be posed in a similar way to when it was trained for 'Jeopardy!'" Jinks says. "Sloan-Kettering and IBM are already developing the first applications using Watson related to lung, breast, and prostate cancers, and aim to begin piloting the solutions to some oncologists in late 2012, with wider distribution planned for late 2013."

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.